These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3275471)
21. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives]. Kostowski W; Płaźnik A Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340 [No Abstract] [Full Text] [Related]
30. Behavioral pharmacology: potential antidepressant and anxiolytic properties. Wesołowska A; Jastrzębska-Więsek M Int Rev Neurobiol; 2011; 96():49-71. PubMed ID: 21329784 [No Abstract] [Full Text] [Related]
31. Panic disorder: the potential role of serotonin reuptake inhibitors. Sheehan DV; Zak JP; Miller JA; Fanous BS J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109 [TBL] [Abstract][Full Text] [Related]
32. Creating more effective antidepressants: clues from the clinic. Rasmussen K Drug Discov Today; 2006 Jul; 11(13-14):623-31. PubMed ID: 16793531 [TBL] [Abstract][Full Text] [Related]
33. Use of serotonergic agents in the clinical assessment of central serotonin function. Murphy DL; Mueller EA; Garrick NA; Aulakh CS J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586 [TBL] [Abstract][Full Text] [Related]
34. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment. Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288 [TBL] [Abstract][Full Text] [Related]
35. Is it possible to modify serotonin receptor sensitivity? Wirz-Justice A; Krauchi K; Lichtsteiner M; Feer H Life Sci; 1978 Sep; 23(12):1249-54. PubMed ID: 309538 [No Abstract] [Full Text] [Related]
36. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. Goodman WK; Charney DS J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056 [TBL] [Abstract][Full Text] [Related]
37. Serotonin and treatment in obsessive-compulsive disorder. March JS; Gutzman LD; Jefferson JW; Greist JH Psychiatr Dev; 1989; 7(1):1-18. PubMed ID: 2508084 [TBL] [Abstract][Full Text] [Related]
39. Fluvoxamine in the treatment of panic disorder with obsessive-compulsive symptoms. Servant D; Bailly D; Parquet PJ Am J Psychiatry; 1988 Sep; 145(9):1174-5. PubMed ID: 3137830 [No Abstract] [Full Text] [Related]
40. The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. Moret C; Briley M Eur J Pharmacol; 2000 Sep; 404(1-2):1-12. PubMed ID: 10980257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]